Abstract
This letter comments on Keertan Dheda and colleagues report of extremely poor treatment outcomes for patients with extensively drug-resistant (XDR) tuberculosis in South Africa. It states that an important strategy to prevent XDR tuberculosis is to ensure adequate treatment for multidrug-resistant (MDR) tuberculosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
